294 related articles for article (PubMed ID: 31486954)
1. Rebalancing metal dyshomeostasis for Alzheimer's disease therapy.
Yang GJ; Liu H; Ma DL; Leung CH
J Biol Inorg Chem; 2019 Dec; 24(8):1159-1170. PubMed ID: 31486954
[TBL] [Abstract][Full Text] [Related]
2. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
3. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
[TBL] [Abstract][Full Text] [Related]
4. The impact of chelating compounds on Cu
Mazur T; Malik M; Bieńko DC
J Inorg Biochem; 2024 Aug; 257():112601. PubMed ID: 38744143
[TBL] [Abstract][Full Text] [Related]
5. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
[TBL] [Abstract][Full Text] [Related]
6. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
Cuajungco MP; Fagét KY
Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
[TBL] [Abstract][Full Text] [Related]
7. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
8. Role of metal dyshomeostasis in Alzheimer's disease.
Bonda DJ; Lee HG; Blair JA; Zhu X; Perry G; Smith MA
Metallomics; 2011 Mar; 3(3):267-70. PubMed ID: 21298161
[TBL] [Abstract][Full Text] [Related]
9. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-beta metal interaction and metal chelation.
Cuajungco MP; Frederickson CJ; Bush AI
Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
[TBL] [Abstract][Full Text] [Related]
11. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
[TBL] [Abstract][Full Text] [Related]
12. Transition metal chelator therapy--a potential treatment for Alzheimer's disease?
Gnjec A; Fonte JA; Atwood C; Martins RN
Front Biosci; 2002 Apr; 7():d1016-23. PubMed ID: 11897554
[TBL] [Abstract][Full Text] [Related]
13. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
14. Current status of metals as therapeutic targets in Alzheimer's disease.
Finefrock AE; Bush AI; Doraiswamy PM
J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
[TBL] [Abstract][Full Text] [Related]
15. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
16. Metal chelation as a potential therapy for Alzheimer's disease.
Cuajungco MP; Fagét KY; Huang X; Tanzi RE; Bush AI
Ann N Y Acad Sci; 2000; 920():292-304. PubMed ID: 11193167
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease, metal ions and metal homeostatic therapy.
Zatta P; Drago D; Bolognin S; Sensi SL
Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
[TBL] [Abstract][Full Text] [Related]
19. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
20. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]